February 21 - Case Conference
Department of Psychiatry and Behavioral Sciences | Grand Rounds Series
Friday, Feb 21, 2020 12:00 p.m. - 1:00 p.m.
Join us as we host Eric Dobson, MD, Danielle Lowe, MD, PhD, Emily Whisler, DO, and Amanda Rice, PharmD, from the Medical University of South Carolina as they present on their case study. Akathisia is one of the most common side effects of anti-psychotic medications, however, it has also been associated with a variety of other medications as well as medical conditions. Akathisia often is misdiagnosed as anxiety, psychosis, or ADHD and may go undiagnosed entirely due to its presentation often lacking observable signs. Despite this, proposed links between akathisia and suicide have made identification and treatment of this side effect paramount. They will discuss a case of akathisia with an unusual cause and review the differential diagnosis and treatment of akathisia.
1. Identify common and rare causes of akathisia.
2. Review the diagnosis and treatment of medication-induced akathisia.
3. Describe the mechanism of action of select unregulated "nootropics" or psychostimulants.
Eric Dobson, MD is a psychiatry resident at the Medical University of South Carolina. He studied biochemistry and film studies at The Ohio State University where his research focused on the creation of materials for targeted cancer imaging. He then completed medical training at University of Cincinnati College of Medicine where his research interests included pediatric anxiety disorders and predictors of placebo response. Since moving to Charleston, Dr. Dobson has co-founded the South Carolina Psychedelic Science Group, an interdisciplinary group that regularly meets to critically appraise emerging literature regarding the benefits and risks of substances like ketamine, psilocybin and MDMA in the treatment of mental illness.
Danielle Lowe is originally from West Virginia where she graduated from Marshall University. She obtained her medical degree and doctorate in biomedical science at Medical University of South Carolina in 2018. She is currently a second-year adult psychiatry resident at MUSC, pursuing a career as a physician scientist in child and adolescent psychiatry. She is interested in Autism Spectrum Disorder and recently co-authored a paper in Autism Research on rTMS for adults with Autism Spectrum Disorder and co-morbid depression.
Dr. Amanda Rice is a current PGY2 Psychiatric Pharmacy Resident at the Medical University of South Carolina and a Board Certified Pharmacotherapy Specialist. She attended Harding University and earned a Bachelor’s Degree in biochemistry and molecular biology with a minor in psychology. She completed her PharmD, with a focus in psychiatric pharmacy, at the University of Oklahoma before coming to MUSC for her PGY1 Pharmacy Residency. Dr. Rice’s research interests include women’s health and transitions of care. Following completion of her residency in June, she is planning to pursue a career in academia.
Emily Whisler, DO is a psychiatry resident at MUSC. At the University of California, Santa Barbara she studied Biology and Global Peace and Security. During that time she became interested in autism and was selected to be a research assistant at the Koegel Autism Center. Subsequently she spent several years as an in home therapist performing Pivotal Response Treatment, a behavioral intervention for children with autism as well as volunteering for Special Olympics. Dr. Whisler returned to school to complete her medical education at Des Moines University where she found her path to psychiatry. Dr. Whisler hopes to continue pursuing these developed interests by completing a fellowship in child and adolescent psychiatry.